Stock listing

OTC:TSOI Therapeutic Solutions International, Inc. Stock

Follow Therapeutic Solutions International, Inc. into a list and get an email when it puts out news.

Therapeutic Solutions International, Inc. logo
Ticker
OTC:TSOI
Asset type
Stock
Sector
Health care
Industry
Biotechnology
Exchange
OTC
Currency
USD

What changed lately

Latest news

All Therapeutic Solutions International, Inc. news

Therapeutic Solutions International, Inc. on 6ix

Sector
Health care
Industry
Biotechnology
News releases
1 in all · newest Apr 23, 2025 · oldest 2025
Decks
1 deck · latest September 2026

Events

QuarterResults
Q3 2024Nov 12, 2024 · Before open
Q2 2024Aug 19, 2024 · After close
Q1 2024May 30, 2024 · After close
Q4 2023Mar 29, 2024 · After close
Q3 2023Nov 14, 2023 · Before open
Q2 2023Aug 21, 2023 · After close
Q1 2023May 16, 2023 · After close
Q4 2022Mar 29, 2023
Q3 2022Nov 17, 2022
Q2 2022Aug 19, 2022
All 16 quarters
QuarterResults
Q1 2022May 23, 2022
Q4 2021Mar 31, 2022
Q3 2021Nov 22, 2021
Q2 2021Aug 13, 2021
Q1 2021Apr 9, 2021
Q4 2020Mar 31, 2021

Open Events

Decks

DeckKindSlidesDate
Investor Presentation (September 2026)Investor deck12 slidesSeptember 2026

Open Decks

Financials

Annual, in USD

Income statement

LineFY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016FY2015FY2014
Revenue99.0K206.8K146.0K62.7K27.5K3.48K2.85K1.91K268.9K0
Cost of revenue36.8K79.4K42.5K12.8K3.02K2.16K8233.19K26.8K0
Gross profit62.2K127.3K103.4K49.9K24.5K1.33K2.03K-1.28K242.1K0
Research and development560.7K1.44M794.8K562.0K27.7K75.0K25.1K11.0K11.0K11.0K
Selling, general and administrative1.05M1.77M1.61M1.34M1.04M1.12M857.9K565.8K306.0K306.0K
Operating income-1.99M-3.28M-2.30M-1.85M-1.04M-1.20M-884.3K-570.9K-327.1K-327.1K
Depreciation and amortization311.8K244.6K18.1K6.98K6.59K195.0K27.5K1.04M21.1K21.1K
EBITDA-1.67M-3.03M-2.29M-1.84M-1.04M-1.00M-856.8K471.2K-306.0K-306.0K
Interest expense423.3K646.1K611.8K302.5K350.7K241.8K53.4K5.55K9.38K0
Income before tax-2.22M-3.88M-2.96M-2.20M-1.70M-1.87M-995.5K-572.6K-537.8K-537.8K
Income tax2.25K1.60K800295.8K350.7K667.1K-830.8K13.8K14.3K0
Net income-2.17M-3.81M-2.96M-2.20M-1.70M-1.87M-995.5K-586.4K-288.8K-288.8K
Earnings per share, basic-0.00-0.00-0.00-0.00-0.00-0.00-0.00-0.00-0.00

Balance sheet

LineFY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016FY2015FY2014
Cash and equivalents27.8K18.0K94.0K252.1K26.4K22.4K2921.9K2.89K2.89K
Short-term investments0000
Receivables19.2K25.4K16.6K2.44K2.90K-1.05K-14.3K90.0K
Inventory22.6K42.4K39.8K5.40K5.18K01.51K36.4K26.8K
Current assets85.9K309.2K1.12M347.5K139.7K135.9K2.60K72.6K188.8K188.8K
Property, plant and equipment281.7K318.2K64.0K5.62K0000
Goodwill0000
Total assets3.29M3.61M1.72M603.5K311.0K206.9K26.5K104.9K201.2K201.2K
Accounts payable404.9K409.2K403.8K309.7K324.9K320.8K343.8K327.6K290.6K290.6K
Current liabilities1.90M2.21M2.50M2.35M2.35M2.02M1.34M684.2K332.5K332.5K
Long-term debt5.51K10.5K15.5K0075.5K0
Total debt888.1K1.08M1.10M1.04M981.6K504.3K456.7K297.0K30.0K
Total liabilities2.01M2.22M2.52M2.38M2.35M2.02M1.34M759.7K332.5K332.5K
Shareholders' equity1.13M1.22M-805.0K-1.78M-2.04M-1.81M-1.31M-654.8K-131.3K-131.3K
Shares outstanding3.17B2.53B2.26B1.91B1.28B896.9M778.2M668.1M196.4M

Cash flow

LineFY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016FY2015FY2014
Cash from operations-1.06M-1.02M-718.9K-663.1K-310.7K-469.2K-366.7K-385.7K-59.6K-332.5K
Capital spending-16.2K-200.0K-260.6K-5.45K-5.45K-5.45K-5.45K000
Free cash flow-1.07M-1.02M-979.5K-668.5K-310.7K-469.2K-366.7K-385.7K-59.6K-332.5K
Cash from investing-24.0K-256.6K-5.45K-5.45K-5.45K-5.45K055.0K55.0K
Cash from financing1.08M943.1K817.4K894.3K314.7K491.5K344.8K405.5K-5.00K267.9K
Dividends paid0000
Share buybacks588.0K01.70K2.82K1.68K202.5K
Change in cash-1.61K-75.2K-158.1K225.8K4.03K22.4K-21.9K19.7K-9.62K-9.62K

Open Financials

Cap table

Built by 6ix from Therapeutic Solutions International, Inc.’s releases

Common shares
5,122,705,536
Fully diluted
5,122,705,536

Fully diluted

LineShares
Common shares5,122,705,536

Share count over time

CountShares
Nov 22, 20265,122,705,536

Open Cap table

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Gerry B Berg
Other companies: Dakota Territory Resource Corp (Director · Nov 12, 2012 – Nov 12, 2012 · Past)
CFO, Director · Nov 21, 2011 – Jan 3, 2019 · Past
Thomas IchimDirector · Oct 16, 2023 – Oct 1, 2024 · Past

Open People

Log in to ask 6ix AI your own questions about Therapeutic Solutions International, Inc.